NEW JERSEY
-
Merck Manuals Tackles Six Hair Loss Misconceptions
Doctor details what men and women should know about alopecia KENILWORTH, N.J., June 6, 2022 /PRNewswire/ -- After this year's Academy Awards, hair loss was a trending topic. Yet much of the conversati…
-
The Vitamin Shoppe Partners with Baranova27 to Donate over Two Tons of Protein Bars and Nutritious Snacks to Communities Impacted by the War in Ukraine
Founded by Aleksandr, Maksim, and Valentin Chmerkovskiy, non-profit Baranova27 has spearheaded large-scale product donation drives in New Jersey to support humanitarian relief efforts in Ukraine SECAU…
-
LG ANNOUNCES U.S. PRICING & AVAILABILITY OF 2022 LG GRAM LAPTOP LINEUP AND DEBUT OF +VIEW PORTABLE MONITOR
Perfect for People on the Move, LG's Premium Laptops Boost Productivity and Security with AI-based Features, While New Portable Monitor Extends the Digital Workspace ENGLEWOOD CLIFFS, N.J., June 6, 20…
-
Linnaeus Therapeutics Announces Presentation of Positive Clinical Data of LNS8801 at 2022 ASCO Annual Meeting
HADDONFIELD, N.J., June 6, 2022 /PRNewswire/ -- Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of no…
-
IRS CP14 Notices Arriving in Taxpayers' Mailboxes Early June, Jackson Hewitt Encourages Taxpayers to Not Ignore
Millions of taxpayers missed the April deadline, payments options available for balance due on unpaid taxes JERSEY CITY, N.J., June 6, 2022 /PRNewswire/ -- Despite the IRS pausing several notices and…
-
PTC Therapeutics to Participate at William Blair 42nd Annual Growth Stock Conference
SOUTH PLAINFIELD, N.J., June 6, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the William Blair 42nd Annual Growth Stock…
-
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home SettingsAdvances BD 2025 Strategy to Accelerate Innovation i…
-
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting
Poster Discussion Features Investigational Safety and Efficacy Data from the Platinum-Resistant Ovarian Cancer Cohort Expansion of a Phase 1 Study Evaluating Farletuzumab Ecteribulin (MORAb-202) in So…
-
Taiho Oncology Announces Updated Efficacy and Safety Data for Futibatinib in Cholangiocarcinoma at 2022 ASCO Annual Meeting
These data are part of a New Drug Application that has been granted priority review by the U.S. Food and Drug Administration PRINCETON, N.J., June 3, 2022 /PRNewswire/ -- Taiho Oncology, Inc. announce…
-
PBF Energy to Participate in the Bank of America Energy Credit Conference
PARSIPPANY, N.J., June 3, 2022 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Bank of America Energy Credit Conference on June 8…
-
Corcentric to Present at the William Blair Growth Stock Conference
CHERRY HILL, N.J., June 3, 2022 /PRNewswire/ -- Corcentric, a leading global provider of payments, procurement, accounts payable, and accounts receivable solutions to enterprise and middle-market comp…
-
Tiffany Monique, Popular Background Vocalist for Beyoncé and More, Releases New Single 'Your Love'
NEWARK, N.J., June 3, 2022 /PRNewswire/ -- Today, singer-songwriter Tiffany Monique, known broadly as Beyoncé's longtime lead background vocalist, releases a new single, 'Your Love' on Spotify, Apple…
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BRIDGEWATER, N.J., June 3, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, t…
-
Preliminary Results Presented at ASCO Demonstrated Promising Clinical Efficacy with Unesbulin in Leiomyosarcoma Study
- Results highlight strength of PTC Therapeutics' scientific platform in targeting difficult-to-treat rare cancer types - SOUTH PLAINFIELD, N.J., June 3, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (N…
-
Provention Bio Announces the Grant of Inducement Awards
RED BANK, N.J., June 3, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today a…
-
Provention Bio to Present at the Jefferies Global Healthcare Conference
RED BANK, N.J., June 3, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that man…
-
Provention Bio Announces Update to Board of Directors
RED BANK, N.J., June 3, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced Dr. Jeff…
-
BD Unveils World's First Spectral Cell Sorter with High-Speed Imaging Technology that Sorts Cells Based on Visual Characteristics
BD FACSDiscover™ S8 Cell Sorter with BD CellView™ Image Technology First to Combine Spectral Flow Cytometry with Sort-Capable Imaging FRANKLIN LAKES, N.J., June 3, 2022 /PRNewswire/ -- BD (Becton, Dic…
-
BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
FRANKLIN LAKES, N.J., June 2, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sach…
-
The Food Fight is Over: TUMS® Declares It is Time to Love Food Back
After Over 10 Years of Fighting the 'Food' Fight, America's #1 Heartburn Brand* is Now Empowering Fans to Flaunt Their Love for Food WARREN, N.J., June 2, 2022 /PRNewswire/ -- GlaxoSmithKline (LSE: GS…